Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Metagenomi Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 67
- +14 vs. Q2 2024
- Shares held
- 11.7M
- −105.1K (−0.9%) vs. Q2 2024
- Total value
- $25.3M
- −$22.5M (−47.1%) vs. Q2 2024
- New holders
- 23
- 21 more added
- Sold out
- 9
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.0M |
| Q3 2025 | 58 | $14.2M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.8M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Bank | 218 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 88 | $0 | 0.00% | +88 | New |
| Capital Performance Advisors LLP | 5 | $11 | 0.00% | +5 | New |
| Nisa Investment Advisors, LLC | 8 | $17 | 0.00% | +8 | New |
| Sterling Capital Management LLC | 12 | $26 | 0.00% | +12 | New |
| Larson Financial Group LLC | 50 | $109 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 97 | $210 | 0.00% | −2,198−95.8% | Reduced |
| California State Teachers Retirement System | 457 | $992 | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 491 | $1.06K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 618 | $1.34K | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 687 | $1.49K | 0.00% | +633+1,172.2% | Added |
| Royal Bank of Canada | 920 | $2.00K | 0.00% | +317+52.6% | Added |
| Advisor Group Holdings, Inc. | 1,469 | $3.19K | 0.00% | +1,469 | New |
| Cubist Systematic Strategies, LLC | 3,237 | $7.02K | 0.00% | +3,237 | New |
| Corebridge Financial, Inc. | 3,374 | $7.32K | 0.00% | −21−0.6% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 3,463 | $7.51K | 0.00% | +3,463 | New |
| Bank of America Corp | 3,622 | $7.86K | 0.00% | +327+9.9% | Added |
| Acadian Asset Management LLC | 3,695 | $8.00K | 0.00% | −1,745−32.1% | Reduced |
| US Bancorp | 4,500 | $9.77K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 4,519 | $9.81K | 0.00% | +4,519 | New |
| Citigroup Inc | 4,568 | $9.91K | 0.00% | +3,178+228.6% | Added |
| Tower Research Capital LLC (TRC) | 5,247 | $11.4K | 0.00% | +872+19.9% | Added |
| Rhumbline Advisers | 5,372 | $11.7K | 0.00% | −1,051−16.4% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 7,415 | $16.1K | 0.00% | +7,415 | New |
| JPMorgan Chase & Co | 8,011 | $17.4K | 0.00% | +5,322+197.9% | Added |
| Barclays PLC | 8,698 | $18.9K | 0.00% | +6,532+301.6% | Added |
| UBS Group AG | 9,061 | $19.7K | 0.00% | +6,903+319.9% | Added |
| Squarepoint Ops LLC | 11,526 | $25.0K | 0.00% | +1,324+13.0% | Added |
| Bank of Montreal | 12,441 | $25.4K | 0.00% | +12,441 | New |
| BNP Paribas Arbitrage, SA | 12,799 | $27.8K | 0.00% | +7,256+130.9% | Added |
| New York State Common Retirement Fund | 13,900 | $30.2K | 0.00% | −12,700−47.7% | Reduced |
| Prelude Capital Management, LLC | 14,074 | $30.5K | 0.00% | +14,074 | New |
| Charles Schwab Investment Management Inc | 14,779 | $32.1K | 0.00% | −30,332−67.2% | Reduced |
| Virtu Financial LLC | 15,263 | $33.0K | 0.00% | +15,263 | New |
| Goldman Sachs Group Inc | 19,629 | $42.6K | 0.00% | +19,629 | New |
| Pathstone Holdings, LLC | 20,648 | $44.8K | 0.00% | +20,648 | New |
| Prudential Financial Inc | 21,800 | $47.3K | 0.00% | +21,800 | New |
| Brown Advisory Inc | 25,006 | $54.3K | 0.00% | +25,006 | New |
| Resolute Partners Group | 26,500 | $57.5K | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 30,300 | $65.8K | 0.00% | +30,300 | New |
| State Street Corp | 30,744 | $66.7K | 0.00% | +270+0.9% | Added |
| Green Alpha Advisors, LLC | 31,693 | $68.8K | 0.05% | +31,693 | New |
| Verition Fund Management LLC | 37,675 | $81.8K | 0.00% | +37,675 | New |
| Wells Fargo & Company | 61,606 | $133.7K | 0.00% | +35,294+134.1% | Added |
| Morgan Stanley | 64,637 | $140.3K | 0.00% | +19,919+44.5% | Added |
| Northern Trust Corp | 78,398 | $170.1K | 0.00% | +64,802+476.6% | Added |
| Two Sigma Investments, LP | 85,606 | $185.8K | 0.00% | +47,912+127.1% | Added |
| Bridgeway Capital Management, LLC | 92,200 | $200.1K | 0.00% | +92,200 | New |
| Jacobs Levy Equity Management, Inc | 136,624 | $296.5K | 0.00% | +92,468+209.4% | Added |
| Marshall Wace, LLP | 168,639 | $365.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 182,100 | $395.2K | 0.00% | +182,100 | New |
| Kestra Advisory Services, LLC | 230,305 | $499.8K | 0.00% | +230,305 | New |
| Pura Vida Investments, LLC | 270,618 | $587.2K | 0.97% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 280,287 | $608.0K | 0.01% | +87,524+45.4% | Added |
| Deep Track Capital, LP | 307,500 | $667.3K | 0.02% | −158,732−34.0% | Reduced |
| Geode Capital Management, LLC | 338,031 | $733.5K | 0.00% | +173,796+105.8% | Added |
| Norges Bank | 360,202 | $781.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 373,903 | $811.4K | 0.00% | +157,737+73.0% | Added |
| Millennium Management LLC | 417,878 | $906.8K | 0.00% | +104,716+33.4% | Added |
| BlackRock, Inc. | 435,662 | $945.4K | 0.00% | +435,662 | New |
| Sozo Ventures GP II, L.P. | 581,577 | $1.26M | 0.65% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 777,768 | $1.69M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 804,462 | $1.75M | 0.00% | +74,610+10.2% | Added |
| PFM Health Sciences, LP | 1,034,002 | $2.24M | 0.13% | −233,000−18.4% | Reduced |
| Farallon Capital Management, L.L.C. | 1,057,201 | $2.29M | 0.01% | −286,000−21.3% | Reduced |
| Ra Capital Management, L.P. | 1,305,239 | $2.83M | 0.03% | −172,510−11.7% | Reduced |
| Novo Holdings A/S | 1,800,000 | $3.91M | 0.19% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −583,041−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −245,692−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −99,002−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,244−100.0% | Sold out |
| Bramshill Investments, LLC | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,053−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |